Susan joined the CCDC in March 2021 as Head of Science, bringing with her nearly three decades of experience in the pharmaceutical industry. She has a BSc in chemistry from Winona State University and a PhD in chemistry from the University of Minnesota (Prof. M.C. Etter). Upon completing her PhD research on hydrogen bond directed cocrystallization, she joined Eli Lilly and Company. There, she founded the solid form design program and for two decades led a team of cross-functional scientists charged with finding commercially-viable crystalline forms for small-molecule drug products. She has contributed to the development of more than 150 compounds, is a named inventor on 12 US patents, and has published over 50 papers and book chapters on key aspects of solid form development.
Her research interests include crystal polymorphism, materials design and engineering, crystal nucleation and growth, structure-property relationships, crystal structure prediction and the digital design of drug products. She was elected Fellow of the Royal Society of Chemistry in 2018 and in 2019 joined the inaugural Scientific Advisory Board of the CCDC. She is also an adjunct professor at Purdue University and currently serves on the CrystEngComm Editorial Board, the Editorial Advisory Boards of Journal of Pharmaceutical Sciences and Pharmaceutical Research, and as a topic editor for Crystal Growth and Design.
Google Scholar: Susan Reutzel-Edens
Orcid ID: https://orcid.org/0000-0003-0806-5565